Our prostate-specific SKP2 humanized mouse model offers a valuable platform for investigating mechanisms of immune evasion and tumor microenvironment reprogramming during prostate carcinogenesis, exploring the combined effects of oncogenes and tumor suppressors, and evaluating potential agents targeting human SKP2 for prostate cancer prevention, interception and therapy. This evidence concerns the gene SKP2 and prostate cancer.